Biomarker development in the precision medicine era: lung cancer as a case study

被引：407

作者：

Vargas, Ashley J. ^{[1
,2
]}

Harris, Curtis C. ^{[1
]}

机构：

[1] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Room 3068A,MSC 425,837 Convent Dr, Bethesda, MD 20892 USA

[2] NCI, Canc Prevent Div, Rockville, MD 20850 USA

来源：

NATURE REVIEWS CANCER | 2016年 / 16卷 / 08期

关键词：

C-REACTIVE PROTEIN; REPORTING RECOMMENDATIONS; GENE-EXPRESSION; INTERNATIONAL-ASSOCIATION; PROGNOSTIC CLASSIFIER; COMPANION DIAGNOSTICS; AFRICAN-AMERICANS; EGFR MUTATIONS; MESSENGER-RNA; NEVER SMOKERS;

D O I：

10.1038/nrc.2016.56

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Precision medicine relies on validated biomarkers with which to better classify patients by their probable disease risk, prognosis and/or response to treatment. Although affordable 'omics'-based technology has enabled faster identification of putative biomarkers, the validation of biomarkers is still stymied by low statistical power and poor reproducibility of results. This Review summarizes the successes and challenges of using different types of molecule as biomarkers, using lung cancer as a key illustrative example. Efforts at the national level of several countries to tie molecular measurement of samples to patient data via electronic medical records are the future of precision medicine research.

引用

页码：525 / 537

页数：13

共 50 条

[41] A Case of Lung Cancer: Precision Medicine and Patient-Centered Approach
不详
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 : S18 - S18
[42] Initiating the Era of "Precision" Lung Cancer Surgery
Rusch, Valerie W.
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (06): : 557 - 558
[43] An integrated workflow for biomarker development using microRNAs in extracellular vesicles for cancer precision medicine
Chen, Yu
Wu, Tan
Zhu, Zhongxu
Huang, Hao
Zhang, Liang
Goel, Ajay
Yang, Mengsu
Wang, Xin
SEMINARS IN CANCER BIOLOGY, 2021, 74 : 134 - 155
[44] Biomarker Testing for Guiding Precision Medicine for Patients With Non-Small Cell Lung Cancer
Fox, Adam H.
Alexander, Mariam
Forcucci, Jessica A.
Silvestri, Gerard A.
CHEST, 2024, 166 (05) : 1239 - 1249
[45] Cancer Biomarker Discovery for Precision Medicine: New Progress
Zou, Jinfeng
Wang, Edwin
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (42) : 7655 - 7671
[46] Percutaneous transthoracic needle biopsy of the lung in the era of precision medicine
Sakai, Hitomi
Takeda, Masayuki
JOURNAL OF THORACIC DISEASE, 2019, 11 : S1213 - S1215
[47] Impact of hemolysis on multiomic pancreatic cancer biomarker discovery: De-risking precision medicine biomarker development
Kiebish, Michael A.
Shah, Punit
Bussberg, Valerie
Tolstikov, Vladimir
Searfoss, Rick
Ofori-Mensa, Kennedy
Grund, Eric M.
Darkwah, Abena
Chen, Emily Y.
Greenwood, Bennett
Ntoso, Ellaine Adu
Rodrigues, Leonardo
Liu, Mia
Granger, Elder
Bountra, Chas
Sarangarajan, Rangaprasad
Moser, A. J.
Narain, Niven R.
CANCER RESEARCH, 2020, 80 (16)
[48] Maximizing quality of life remains an ultimate goal in the era of precision medicine: exemplified by lung cancer
Yang, Ping
PRECISION CLINICAL MEDICINE, 2019, 2 (01) : 8 - 12
[49] Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer
Liu, Xiaomin
Wang, Ping
Zhang, Caiyan
Ma, Zhongliang
ONCOTARGET, 2017, 8 (30) : 50209 - 50220
[50] Advancements in the diagnosis and treatment of sub-centimeter lung cancer in the era of precision medicine (Review)
Wang, Xiao
Shi, Jingwei
Liu, Zhengcheng
MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (04)

← 1 2 3 4 5 →